Modified proteins and peptides

The present disclosure relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g., fusions...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ashman, Claire, Morley, Peter, Lewis, Alan Peter, Birchler, Mary, Holland, Claire, Sandal, Thomas, Steward, Michael, De Wildt, Rudolf M. T
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Ashman, Claire
Morley, Peter
Lewis, Alan Peter
Birchler, Mary
Holland, Claire
Sandal, Thomas
Steward, Michael
De Wildt, Rudolf M. T
description The present disclosure relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g., fusions and conjugates) comprise proteins, peptides, antigen binding molecules, antibodies or antibody fragments such as single variable domains. The disclosure further relates to uses and formulations of compositions comprising such modified C-terminally extended and/or amino acid substituted molecules and also to methods of production and expression of these.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US10808040B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US10808040B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US10808040B23</originalsourceid><addsrcrecordid>eNrjZJDzzU_JTMtMTVEoKMovSc3MK1ZIzANyUgtKMlNSi3kYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGBBRCaGDgZGROjBgABXCSp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Modified proteins and peptides</title><source>esp@cenet</source><creator>Ashman, Claire ; Morley, Peter ; Lewis, Alan Peter ; Birchler, Mary ; Holland, Claire ; Sandal, Thomas ; Steward, Michael ; De Wildt, Rudolf M. T</creator><creatorcontrib>Ashman, Claire ; Morley, Peter ; Lewis, Alan Peter ; Birchler, Mary ; Holland, Claire ; Sandal, Thomas ; Steward, Michael ; De Wildt, Rudolf M. T</creatorcontrib><description>The present disclosure relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g., fusions and conjugates) comprise proteins, peptides, antigen binding molecules, antibodies or antibody fragments such as single variable domains. The disclosure further relates to uses and formulations of compositions comprising such modified C-terminally extended and/or amino acid substituted molecules and also to methods of production and expression of these.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201020&amp;DB=EPODOC&amp;CC=US&amp;NR=10808040B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201020&amp;DB=EPODOC&amp;CC=US&amp;NR=10808040B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ashman, Claire</creatorcontrib><creatorcontrib>Morley, Peter</creatorcontrib><creatorcontrib>Lewis, Alan Peter</creatorcontrib><creatorcontrib>Birchler, Mary</creatorcontrib><creatorcontrib>Holland, Claire</creatorcontrib><creatorcontrib>Sandal, Thomas</creatorcontrib><creatorcontrib>Steward, Michael</creatorcontrib><creatorcontrib>De Wildt, Rudolf M. T</creatorcontrib><title>Modified proteins and peptides</title><description>The present disclosure relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g., fusions and conjugates) comprise proteins, peptides, antigen binding molecules, antibodies or antibody fragments such as single variable domains. The disclosure further relates to uses and formulations of compositions comprising such modified C-terminally extended and/or amino acid substituted molecules and also to methods of production and expression of these.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDzzU_JTMtMTVEoKMovSc3MK1ZIzANyUgtKMlNSi3kYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGBBRCaGDgZGROjBgABXCSp</recordid><startdate>20201020</startdate><enddate>20201020</enddate><creator>Ashman, Claire</creator><creator>Morley, Peter</creator><creator>Lewis, Alan Peter</creator><creator>Birchler, Mary</creator><creator>Holland, Claire</creator><creator>Sandal, Thomas</creator><creator>Steward, Michael</creator><creator>De Wildt, Rudolf M. T</creator><scope>EVB</scope></search><sort><creationdate>20201020</creationdate><title>Modified proteins and peptides</title><author>Ashman, Claire ; Morley, Peter ; Lewis, Alan Peter ; Birchler, Mary ; Holland, Claire ; Sandal, Thomas ; Steward, Michael ; De Wildt, Rudolf M. T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US10808040B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Ashman, Claire</creatorcontrib><creatorcontrib>Morley, Peter</creatorcontrib><creatorcontrib>Lewis, Alan Peter</creatorcontrib><creatorcontrib>Birchler, Mary</creatorcontrib><creatorcontrib>Holland, Claire</creatorcontrib><creatorcontrib>Sandal, Thomas</creatorcontrib><creatorcontrib>Steward, Michael</creatorcontrib><creatorcontrib>De Wildt, Rudolf M. T</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ashman, Claire</au><au>Morley, Peter</au><au>Lewis, Alan Peter</au><au>Birchler, Mary</au><au>Holland, Claire</au><au>Sandal, Thomas</au><au>Steward, Michael</au><au>De Wildt, Rudolf M. T</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Modified proteins and peptides</title><date>2020-10-20</date><risdate>2020</risdate><abstract>The present disclosure relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g., fusions and conjugates) comprise proteins, peptides, antigen binding molecules, antibodies or antibody fragments such as single variable domains. The disclosure further relates to uses and formulations of compositions comprising such modified C-terminally extended and/or amino acid substituted molecules and also to methods of production and expression of these.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US10808040B2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Modified proteins and peptides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T18%3A17%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ashman,%20Claire&rft.date=2020-10-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS10808040B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true